Abstract
Coronavirus disease 2019 (COVID-19) is affecting millions of patients worldwide. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the family Coronaviridae, with 80% genomic similarities to SARS-CoV. Lymphopenia was commonly seen in infected patients and has a correlation to disease severity. Thrombocytopenia, coagulation abnormalities, and disseminated intravascular coagulation were observed in COVID-19 patients, especially those with critical illness and non-survivors. This pandemic has caused disruption in communities and hospital services, as well as straining blood product supply, affecting chemotherapy treatment and haematopoietic stem cell transplantation schedule. In this article, we review the haematological manifestations of the disease and its implication on the management of patients with haematological disorders.
References
1.
Li
G
, Fan
Y
, Lai
Y
, Han
T
, Li
Z
, Zhou
P
, et al. Coronavirus infections and immune responses
. J Med Virol
. 2020
Apr
;92
(4
):424
–32
.
[PubMed]
0146-66152.
Wu
F
, Zhao
S
, Yu
B
, Chen
YM
, Wang
W
, Song
ZG
, et al. A new coronavirus associated with human respiratory disease in China
. Nature
. 2020
Mar
;579
(7798
):265
–9
.
[PubMed]
0028-08363.
Zhou
P
, Yang
XL
, Wang
XG
, Hu
B
, Zhang
L
, Zhang
W
, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin
. Nature
. 2020
Mar
;579
(7798
):270
–3
.
[PubMed]
0028-08364.
WHO Health Emergency Dashboard Coronavirus (COVID-19): World Health Organization (WHO); Available from: https://covid19.who.int. Accessed on 30 April 2020.
5.
Li
Q
, Guan
X
, Wu
P
, Wang
X
, Zhou
L
, Tong
Y
, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
. N Engl J Med
. 2020
Mar
;382
(13
):1199
–207
.
[PubMed]
0028-47936.
Wu
JT
, Leung
K
, Leung
GM
. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
. Lancet
. 2020
Feb
;395
(10225
):689
–97
.
[PubMed]
0140-67367.
Zhang
S
, Diao
M
, Yu
W
, Pei
L
, Lin
Z
, Chen
D
. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis
. Int J Infect Dis
. 2020
Apr
;93
:201
–4
.
[PubMed]
1201-97128.
Zhao
S
, Lin
Q
, Ran
J
, Musa
SS
, Yang
G
, Wang
W
, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak
. Int J Infect Dis
. 2020
Mar
;92
:214
–7
.
[PubMed]
1201-97129.
Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment
. In: Commission CNH, editor. 7th edition ed2020
.10.
Rosenbaum
L
. The Untold Toll - The Pandemic’s Effects on Patients without Covid-19
. N Engl J Med
. 2020
Jun
;382
(24
):2368
–71
.
[PubMed]
0028-479311.
Guan
WJ
, Ni
ZY
, Hu
Y
, Liang
WH
, Ou
CQ
, He
JX
, et al.; China Medical Treatment Expert Group for Covid-19
. Clinical Characteristics of Coronavirus Disease 2019 in China
. N Engl J Med
. 2020
Apr
;382
(18
):1708
–20
.
[PubMed]
0028-479312.
Chen
N
, Zhou
M
, Dong
X
, Qu
J
, Gong
F
, Han
Y
, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
. Lancet
. 2020
Feb
;395
(10223
):507
–13
.
[PubMed]
0140-673613.
Wang
D
, Hu
B
, Hu
C
, Zhu
F
, Liu
X
, Zhang
J
, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan
. China
: JAMA
; 2020
. 14.
Zhu
W
, Xie
K
, Lu
H
, Xu
L
, Zhou
S
, Fang
S
. Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China
. J Med Virol
. 2020
Mar
;jmv.25763
.
[PubMed]
0146-661515.
Zhang
JJ
, Dong
X
, Cao
YY
, Yuan
YD
, Yang
YB
, Yan
YQ
, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020
.16.
Yang
W
, Cao
Q
, Qin
L
, Wang
X
, Cheng
Z
, Pan
A
, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China
. J Infect
. 2020
Apr
;80
(4
):388
–93
.
[PubMed]
0163-445317.
Wan
S
, Xiang
Y
, Fang
W
, Zheng
Y
, Li
B
, Hu
Y
, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing
. J Med Virol
. 2020
Jul
;92
(7
):797
–806
.
[PubMed]
0146-661518.
Han
R
, Huang
L
, Jiang
H
, Dong
J
, Peng
H
, Zhang
D
. Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia
. AJR Am J Roentgenol
. 2020
Mar
;215
(2
):1
–6
.
[PubMed]
0361-803X19.
Liu
K
, Fang
YY
, Deng
Y
, Liu
W
, Wang
MF
, Ma
JP
, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
. Chin Med J (Engl)
. 2020
May
;133
(9
):1025
–31
.
[PubMed]
0366-699920.
Liu
K
, Chen
Y
, Lin
R
, Han
K
. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients
. J Infect
. 2020
Jun
;80
(6
):e14
–8
.
[PubMed]
0163-445321.
Liu
M
, He
P
, Liu
HG
, Wang
XJ
, Li
FJ
, Chen
S
, et al. [Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia]
. Zhonghua Jie He He Hu Xi Za Zhi
. 2020
Feb
;43
(0
):E016
.
[PubMed]
1001-093922.
Chen
L
, Liu
HG
, Liu
W
, Liu
J
, Liu
K
, Shang
J
, et al. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]
. Zhonghua Jie He He Hu Xi Za Zhi
. 2020
Feb
;43
(0
):E005
.
[PubMed]
1001-093923.
Zhou
S
, Wang
Y
, Zhu
T
, Xia
L
. CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China
. AJR Am J Roentgenol
. 2020
Jun
;214
(6
):1287
–94
.
[PubMed]
0361-803X24.
Xu
YH
, Dong
JH
, An
WM
, Lv
XY
, Yin
XP
, Zhang
JZ
, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2
. J Infect
. 2020
Apr
;80
(4
):394
–400
.
[PubMed]
0163-445325.
Wu
J
, Wu
X
, Zeng
W
, Guo
D
, Fang
Z
, Chen
L
, et al. Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features
. Invest Radiol
. 2020
May
;55
(5
):257
–61
.
[PubMed]
0020-999626.
Song
F
, Shi
N
, Shan
F
, Zhang
Z
, Shen
J
, Lu
H
, et al. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
. Radiology
. 2020
Apr
;295
(1
):210
–7
.
[PubMed]
0033-841927.
Xu
XW
, Wu
XX
, Jiang
XG
, Xu
KJ
, Ying
LJ
, Ma
CL
, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
. BMJ
. 2020
Feb
;368
:m606
.
[PubMed]
0959-813828.
Zheng
F
, Tang
W
, Li
H
, Huang
YX
, Xie
YL
, Zhou
ZG
. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha
. Eur Rev Med Pharmacol Sci
. 2020
Mar
;24
(6
):3404
–10
.
[PubMed]
2284-072929.
Chen
X
, Yang
Y
, Huang
M
, Liu
L
, Zhang
X
, Xu
J
, et al. Differences between COVID-19 and suspected then confirmed SARS-CoV-2-negative pneumonia: A retrospective study from a single center
. J Med Virol
. 2020
Apr
.
[PubMed]
0146-661530.
Huang
C
, Wang
Y
, Li
X
, Ren
L
, Zhao
J
, Hu
Y
, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
. Lancet
. 2020
Feb
;395
(10223
):497
–506
.
[PubMed]
0140-673631.
Richardson
S
, Hirsch
JS
, Narasimhan
M
, Crawford
JM
, McGinn
T
, Davidson
KW
, et al.; and the Northwell COVID-19 Research Consortium
. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
. JAMA
. 2020
Apr
;323
(20
):2052
.
[PubMed]
0098-748432.
Fan
BE
, Chong
VC
, Chan
SS
, Lim
GH
, Lim
KG
, Tan
GB
, et al. Hematologic parameters in patients with COVID-19 infection
. Am J Hematol
. 2020
.0361-860933.
Kim
ES
, Chin
BS
, Kang
CK
, Kim
NJ
, Kang
YM
, Choi
JP
, et al.; Korea National Committee for Clinical Management of COVID-19
. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19
. J Korean Med Sci
. 2020
Apr
;35
(13
):e142
.
[PubMed]
1011-893434.
Zhou
F
, Yu
T
, Du
R
, Fan
G
, Liu
Y
, Liu
Z
, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
. Lancet
. 2020
Mar
;395
(10229
):1054
–62
.
[PubMed]
0140-673635.
Zhang
G
, Zhang
J
, Wang
B
, Zhu
X
, Wang
Q
, Qiu
S
. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis
. Respir Res
. 2020
Mar
;21
(1
):74
.
[PubMed]
1465-992136.
Wu
C
, Chen
X
, Cai
Y
, Xia
J
, Zhou
X
, Xu
S
, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020
.37.
Arentz
M
, Yim
E
, Klaff
L
, Lokhandwala
S
, Riedo
FX
, Chong
M
, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
. JAMA
. 2020
Mar
;323
(16
):1612
.
[PubMed]
0098-748438.
Bhatraju
PK
, Ghassemieh
BJ
, Nichols
M
, Kim
R
, Jerome
KR
, Nalla
AK
, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series
. N Engl J Med
. 2020
May
;382
(21
):2012
–22
.
[PubMed]
0028-479339.
Yang
X
, Yu
Y
, Xu
J
, Shu
H
, Xia
J
, Liu
H
, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
. Lancet Respir Med
. 2020
May
;8
(5
):475
–81
.
[PubMed]
2213-260040.
Qin
C
, Zhou
L
, Hu
Z
, Zhang
S
, Yang
S
, Tao
Y
, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020
.41.
Chen
G
, Wu
D
, Guo
W
, Cao
Y
, Huang
D
, Wang
H
, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019
. J Clin Invest
. 2020
May
;130
(5
):2620
–9
.
[PubMed]
0021-973842.
Liu
Z
, Long
W
, Tu
M
, Chen
S
, Huang
Y
, Wang
S
, et al. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
. J Infect
. 2020
Apr
;S0163-4453(20)30182-1
.
[PubMed]
1532-274243.
Liu
Y
, Yang
Y
, Zhang
C
, Huang
F
, Wang
F
, Yuan
J
, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
. Sci China Life Sci
. 2020
Mar
;63
(3
):364
–74
.
[PubMed]
1674-730544.
Liu
Y
, Liao
W
, Wan
L
, Xiang
T
, Zhang
W
. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19
. Viral Immunol
. 2020
Apr
;vim.2020.0062
.
[PubMed]
0882-824545.
Jiang
M
, Guo
Y
, Luo
Q
, Huang
Z
, Zhao
R
, Liu
S
, et al. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19
. J Infect Dis
. 2020
;222
(2
):198
–202
. 0022-189946.
Wan
S
, Yi
Q
, Fan
S
, Lv
J
, Zhang
X
, Guo
L
, et al. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients
. Br J Haematol
. 2020
May
;189
(3
):428
–37
.
[PubMed]
0007-104847.
Liu
J
, Li
S
, Liu
J
, Liang
B
, Wang
X
, Wang
H
, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
. EBioMedicine
. 2020
May
;55
:102763
.
[PubMed]
2352-396448.
Wang
F
, Nie
J
, Wang
H
, Zhao
Q
, Xiong
Y
, Deng
L
, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia
. J Infect Dis
. 2020
May
;221
(11
):1762
–9
.
[PubMed]
0022-189949.
Ling
Y
, Xu
SB
, Lin
YX
, Tian
D
, Zhu
ZQ
, Dai
FH
, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients
. Chin Med J (Engl)
. 2020
May
;133
(9
):1039
–43
.
[PubMed]
0366-699950.
Zheng
M
, Gao
Y
, Wang
G
, Song
G
, Liu
S
, Sun
D
, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients
. Cell Mol Immunol
. 2020
May
;17
(5
):533
–5
.
[PubMed]
1672-768151.
Channappanavar
R
, Zhao
J
, Perlman
S
. T cell-mediated immune response to respiratory coronaviruses
. Immunol Res
. 2014
Aug
;59
(1-3
):118
–28
.
[PubMed]
0257-277X52.
Cao
X
. COVID-19: immunopathology and its implications for therapy
. Nat Rev Immunol
. 2020
May
;20
(5
):269
–70
.
[PubMed]
1474-173353.
Henry
BM
, de Oliveira
MH
, Benoit
S
, Plebani
M
, Lippi
G
. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
. Clin Chem Lab Med
. 2020
Jun
;58
(7
):1021
–8
.
[PubMed]
1434-662154.
Lippi
G
, Plebani
M
, Henry
BM
. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
. Clin Chim Acta
. 2020
Jul
;506
:145
–8
.
[PubMed]
0009-898155.
Metlay
JP
, Waterer
GW
, Long
AC
, Anzueto
A
, Brozek
J
, Crothers
K
, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
. Am J Respir Crit Care Med
. 2019
Oct
;200
(7
):e45
–67
.
[PubMed]
1073-449X56.
Yang
X
, Yang
Q
, Wang
Y
, Wu
Y
, Xu
J
, Yu
Y
, et al. Thrombocytopenia and its association with mortality in patients with COVID-19
. J Thromb Haemost
. 2020
Jun
;18
(6
):1469
–72
.
[PubMed]
1538-793357.
Li
Q
, Cao
Y
, Chen
L
, Wu
D
, Yu
J
, Wang
H
, et al. Hematological features of persons with COVID-19
. Leukemia
. 2020
Jun
.
[PubMed]
1476-555158.
Liu
Y
, Sun
W
, Guo
Y
, Chen
L
, Zhang
L
, Zhao
S
, et al. Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study
. Platelets
. 2020
May
;31
(4
):490
–6
.
[PubMed]
0953-710459.
Qu
R
, Ling
Y
, Zhang
YH
, Wei
LY
, Chen
X
, Li
XM
, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19
. J Med Virol
. 2020
Mar
;jmv.25767
.
[PubMed]
0146-661560.
Yang
AP
, Liu
JP
, Tao
WQ
, Li
HM
. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
. Int Immunopharmacol
. 2020
Jul
;84
:106504
.
[PubMed]
1567-576961.
Yang
M
, Hon
KL
, Li
K
, Fok
TF
, Li
CK
. The effect of SARS coronavirus on blood system: its clinical findings and the pathophysiologic hypothesis
. Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2003
Jun
;11
(3
):217
–21
.
[PubMed]
1009-213762.
Yang
M
, Ng
MH
, Li
CK
. Thrombocytopenia in patients with severe acute respiratory syndrome (review)
. [review]
. Hematology
. 2005
Apr
;10
(2
):101
–5
.
[PubMed]
1024-533263.
Chen
RF
, Chang
JC
, Yeh
WT
, Lee
CH
, Liu
JW
, Eng
HL
, et al. Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)
. Microbes Infect
. 2006
Jan
;8
(1
):122
–7
.
[PubMed]
1286-457964.
Xu
P
, Zhou
Q
, Xu
J
. Mechanism of thrombocytopenia in COVID-19 patients
. Ann Hematol
. 2020
Jun
;99
(6
):1205
–8
.
[PubMed]
0939-555565.
Mehta
P
, McAuley
DF
, Brown
M
, Sanchez
E
, Tattersall
RS
, Manson
JJ
; HLH Across Speciality Collaboration, UK
. COVID-19: consider cytokine storm syndromes and immunosuppression
. Lancet
. 2020
Mar
;395
(10229
):1033
–4
.
[PubMed]
0140-673666.
Wada
H
, Thachil
J
, Di Nisio
M
, Mathew
P
, Kurosawa
S
, Gando
S
, et al.; The Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis
. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines
. J Thromb Haemost
. 2013
Feb
.
[PubMed]
1538-793367.
Fan
BE
, Ong
KH
, Chan
SS
, Young
BE
, Chong
VC
, Chen
SP
, et al. Blood and blood product use during COVID-19 infection
. Am J Hematol
. 2020
Jul
;95
(7
):E158
–60
.
[PubMed]
0361-860968.
Lazarian
G
, Quinquenel
A
, Bellal
M
, Siavellis
J
, Jacquy
C
, Re
D
, et al. Autoimmune haemolytic anaemia associated with COVID-19 infection
. Br J Haematol
. 2020
Jul
;190
(1
):29
–31
.
[PubMed]
0007-104869.
Xiao
F
, Tang
M
, Zheng
X
, Liu
Y
, Li
X
, Shan
H.
Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology. 2020
;158(6):1831-3 e3.70.
Lin
L
, Jiang
X
, Zhang
Z
, Huang
S
, Zhang
Z
, Fang
Z
, et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection
. Gut
. 2020
Jun
;69
(6
):997
–1001
.
[PubMed]
0017-574971.
Khalili
JS
, Zhu
H
, Mak
NS
, Yan
Y
, Zhu
Y
. Novel coronavirus treatment with ribavirin: groundwork for an evaluation concerning COVID-19
. J Med Virol
. 2020
Jul
;92
(7
):740
–6
.
[PubMed]
0146-661572.
Lu
CC
, Chen
MY
, Lee
WS
, Chang
YL
. Potential therapeutic agents against COVID-19: what we know so far
. J Chin Med Assoc
. 2020
Jun
;83
(6
):534
–6
.
[PubMed]
1726-490173.
Wong
RS
, Wu
A
, To
KF
, Lee
N
, Lam
CW
, Wong
CK
, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis
. BMJ
. 2003
Jun
;326
(7403
):1358
–62
.
[PubMed]
0959-813874.
Zeng
YM
, Xu
XL
, He
XQ
, Tang
SQ
, Li
Y
, Huang
YQ
, et al. Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
. Chin Med J (Engl)
. 2020
May
;133
(9
):1132
–4
.
[PubMed]
0366-699975.
Myles
N
, von Wielligh
J
, Kyriacou
M
, Ventrice
T
, To
LB
. A cohort study assessing the impact of small volume blood tubes on diagnostic test quality and iatrogenic blood loss in a cohort of adult haematology patients
. Intern Med J
. 2018
Jul
;48
(7
):817
–21
.
[PubMed]
1444-090376.
Litton
E
, Latham
P
, Inman
J
, Luo
J
, Allan
P
. Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis
. Intensive Care Med
. 2019
Sep
;45
(9
):1190
–9
.
[PubMed]
0342-464277.
Baron
DM
, Franchini
M
, Goobie
SM
, Javidroozi
M
, Klein
AA
, Lasocki
S
, et al. Patient blood management during the COVID-19 pandemic: a narrative review
. Anaesthesia
. 2020
Aug
;75
(8
):1105
–13
.
[PubMed]
0003-240978.
Han
H
, Yang
L
, Liu
R
, Liu
F
, Wu
KL
, Li
J
, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
. Clin Chem Lab Med
. 2020
Jun
;58
(7
):1116
–20
.
[PubMed]
1434-662179.
Tang
N
, Li
D
, Wang
X
, Sun
Z
. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
. J Thromb Haemost
. 2020
Apr
;18
(4
):844
–7
.
[PubMed]
1538-793380.
Voves
C
, Wuillemin
WA
, Zeerleder
S
. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients
. Blood Coagul Fibrinolysis
. 2006
Sep
;17
(6
):445
–51
.
[PubMed]
0957-523581.
Zhang
L
, Yan
X
, Fan
Q
, Liu
H
, Liu
X
, Liu
Z
, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19
. J Thromb Haemost
. 2020
Jun
;18
(6
):1324
–9
.
[PubMed]
1538-793382.
Xiong
M
, Liang
X
, Wei
YD
. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis
. Br J Haematol
. 2020
Jun
;189
(6
):1050
–2
.
[PubMed]
0007-104883.
Spiezia
L
, Boscolo
A
, Poletto
F
, Cerruti
L
, Tiberio
I
, Campello
E
, et al. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure
. Thromb Haemost
. 2020
Jun
;120
(6
):998
–1000
.
[PubMed]
0340-624584.
Giannis
D
, Ziogas
IA
, Gianni
P
. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
. J Clin Virol
. 2020
Jun
;127
:104362
.
[PubMed]
1386-653285.
Violi
F
, Pastori
D
, Cangemi
R
, Pignatelli
P
, Loffredo
L
. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge
. Thromb Haemost
. 2020
Jun
;120
(6
):949
–56
.
[PubMed]
0340-624586.
Tang
N
, Bai
H
, Chen
X
, Gong
J
, Li
D
, Sun
Z
. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
. J Thromb Haemost
. 2020
May
;18
(5
):1094
–9
.
[PubMed]
1538-793387.
Iba
T
, Levy
JH
, Warkentin
TE
, Thachil
J
, van der Poll
T
, Levi
M
; Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Critical Care of the International Society on Thrombosis and Haemostasis
. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation
. J Thromb Haemost
. 2019
Nov
;17
(11
):1989
–94
.
[PubMed]
1538-793388.
Yin
S
, Huang
M
, Li
D
, Tang
N
. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
. J Thromb Thrombolysis
. 2020
Apr
.
[PubMed]
0929-530589.
Cui
S
, Chen
S
, Li
X
, Liu
S
, Wang
F
. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
. J Thromb Haemost
. 2020
Jun
;18
(6
):1421
–4
.
[PubMed]
1538-793390.
Klok
FA
, Kruip
M
, van der Meer
NJ
, Arbous
MS
, Gommers
D
, Kant
KM
, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19
. Thromb Res
. 2020
;191
:145
–7
. 0049-384891.
Helms
J
, Tacquard
C
, Severac
F
, Leonard-Lorant
I
, Ohana
M
, Delabranche
X
, et al.; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis)
. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
. Intensive Care Med
. 2020
Jun
;46
(6
):1089
–98
.
[PubMed]
0342-464292.
Llitjos
JF
, Leclerc
M
, Chochois
C
, Monsallier
JM
, Ramakers
M
, Auvray
M
, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
. J Thromb Haemost
. 2020
Jul
;18
(7
):1743
–6
.
[PubMed]
1538-793393.
Wichmann
D
, Sperhake
JP
, Lütgehetmann
M
, Steurer
S
, Edler
C
, Heinemann
A
, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
. Ann Intern Med
. 2020
May
;M20-2003
.
[PubMed]
0003-481994.
Ackermann
M
, Verleden
SE
, Kuehnel
M
, Haverich
A
, Welte
T
, Laenger
F
, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
. N Engl J Med
. 2020
Jul
;383
(2
):120
–8
.
[PubMed]
0028-479395.
Siddamreddy
S
, Thotakura
R
, Dandu
V
, Kanuru
S
, Meegada
S
. Corona Virus Disease 2019 (COVID-19) Presenting as Acute ST Elevation Myocardial Infarction
. Cureus
. 2020
Apr
;12
(4
):e7782
.
[PubMed]
2168-818496.
Oxley
TJ
, Mocco
J
, Majidi
S
, Kellner
CP
, Shoirah
H
, Singh
IP
, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
. N Engl J Med
. 2020
May
;382
(20
):e60
.
[PubMed]
0028-479397.
Mao
L
, Jin
H
, Wang
M
, Hu
Y
, Chen
S
, He
Q
, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020
.98.
Panigada
M
, Bottino
N
, Tagliabue
P
, Grasselli
G
, Novembrino
C
, Chantarangkul
V
, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
. J Thromb Haemost
. 2020
Jul
;18
(7
):1738
–42
.
[PubMed]
1538-793399.
Middeldorp
S
, Coppens
M
, van Haaps
TF
, Foppen
M
, Vlaar
AP
, Müller
MC
, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19
. J Thromb Haemost
. 2020
May
;jth.14888
.
[PubMed]
1538-7933100.
Lodigiani
C
, Iapichino
G
, Carenzo
L
, Cecconi
M
, Ferrazzi
P
, Sebastian
T
, et al.; Humanitas COVID-19 Task Force
. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
. Thromb Res
. 2020
Jul
;191
:9
–14
.
[PubMed]
0049-3848101.
Fogarty
H
, Townsend
L
, Ni Cheallaigh
C
, Bergin
C
, Martin-Loeches
I
, Browne
P
, et al. More on COVID-19 coagulopathy in Caucasian patients
. Br J Haematol
. 2020
Jun
;189
(6
):1060
–1
.
[PubMed]
0007-1048102.
Thachil
J
, Tang
N
, Gando
S
, Falanga
A
, Cattaneo
M
, Levi
M
, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19
. J Thromb Haemost
. 2020
May
;18
(5
):1023
–6
.
[PubMed]
1538-7933103.
Testa
S
, Paoletti
O
, Giorgi-Pierfranceschi
M
, Pan
A
. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
. Intern Emerg Med
. 2020
Apr
.
[PubMed]
1828-0447104.
American Society of Hematology (ASH) recommendations on Coronavirus disease and COVID-19. Available from: https://www.hematology.org/covid-19. Accessed on 8 May 2020.
105.
Akima
S
, McLintock
C
, Hunt
BJ
. RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19
. J Thromb Haemost
. 2020
Apr
;jth.14853
.
[PubMed]
1538-7933106.
Barrett
CD
, Moore
HB
, Yaffe
MB
, Moore
EE
. ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment
. J Thromb Haemost
. 2020
Apr
;jth.14860
.
[PubMed]
1538-7933107.
Zhai
Z
, Li
C
, Chen
Y
, Gerotziafas
G
, Zhang
Z
, Wan
J
, et al.; Prevention Treatment of VTE Associated with COVID-19 Infection Consensus Statement Group
. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines
. Thromb Haemost
. 2020
Jun
;120
(6
):937
–48
.
[PubMed]
0340-6245108.
Pagano
MB
, Hess
JR
, Tsang
HC
, Staley
E
, Gernsheimer
T
, Sen
N
, et al. Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State
. Transfusion
. 2020
May
;60
(5
):908
–11
.
[PubMed]
0041-1132109.
Mohammadi
S
, Tabatabaei Yazdi
SM
, Eshghi
P
, Norooznezhad
AH
. Coronavirus disease 2019 (COVID-19) and decrease in blood donation: experience of Iranian Blood Transfusion Organization (IBTO)
. Vox Sang
. 2020
Apr
;vox.12930
.
[PubMed]
0042-9007110.
Chang
L
, Yan
Y
, Wang
L
. Coronavirus Disease 2019: Coronaviruses and Blood Safety
. Transfus Med Rev
. 2020
Apr
;34
(2
):75
–80
.
[PubMed]
0887-7963111.
American Association of Blood Bank (AABB)'s Coronavirus Resources. Available from: http://www.aabb.org/advocacy/regulatorygovernment/Pages/AABB-Coronavirus-Resources.aspx. Accessed on 8 May 2020.
112.
Keil
SD
, Ragan
I
, Yonemura
S
, Hartson
L
, Dart
NK
, Bowen
R
. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment
. Vox Sang
. 2020
Apr
;vox.12937
.
[PubMed]
0042-9007113.
He
W
, Chen
L
, Chen
L
, Yuan
G
, Fang
Y
, Chen
W
, et al. COVID-19 in persons with haematological cancers
. Leukemia
. 2020
Jun
;34
(6
):1637
–45
.
[PubMed]
0887-6924114.
Gale
RP
. Perspective: SARS-CoV-2, COVID-19 and Haematologists
. Acta Haematol
. 2020
May
;•••
:1
–4
.
[PubMed]
1421-9662115.
Li
W
, Wang
D
, Guo
J
, Yuan
G
, Yang
Z
, Gale
RP
, et al.; Hubei Anti-Cancer Association
. COVID-19 in persons with chronic myeloid leukaemia
. Leukemia
. 2020
Jul
;34
(7
):1799
–804
.
[PubMed]
0887-6924116.
Stukel
TA
, Schull
MJ
, Guttmann
A
, Alter
DA
, Li
P
, Vermeulen
MJ
, et al. Health impact of hospital restrictions on seriously ill hospitalized patients: lessons from the Toronto SARS outbreak
. Med Care
. 2008
Sep
;46
(9
):991
–7
.
[PubMed]
0025-7079117.
Hanna
TP
, Evans
GA
, Booth
CM
. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic
. Nat Rev Clin Oncol
. 2020
May
;17
(5
):268
–70
.
[PubMed]
1759-4774118.
Terpos
E
, Engelhardt
M
, Cook
G
, Gay
F
, Mateos
MV
, Ntanasis-Stathopoulos
I
, et al. Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)
. Leukemia
. 2020
May
.
[PubMed]
0887-6924119.
International Myeloma Society Recommendations for the Management of Myeloma Patients During the COVID-19 Pandemic
. 2020
. Available from: https://cms.cws.net/content/beta.myelomasociety.org/files/IMS%20recommendations%20for%20Physicians%20Final.pdf. Accessed on 8 May 2020.120.
European Hematology Association (EHA) COVID-19 Hematology Hub
. Available from: https://ehaweb.org/. Accessed on 6 June 2020.121.
Dombret
H
. Granulocyte colony-stimulating factor in combination with intensive chemotherapy in the treatment of acute myeloid leukemia
. Leuk Res
. 1998
Dec
;22
(12
):1137
–42
.
[PubMed]
0145-2126122.
Wang
L
, Baser
O
, Kutikova
L
, Page
JH
, Barron
R
. The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
. Support Care Cancer
. 2015
Nov
;23
(11
):3131
–40
.
[PubMed]
0941-4355123.
Jazieh
AR
, Al Hadab
A
, Al Olayan
A
, AlHejazi
A
, Al Safi
F
, Al Qarni
A
, et al. Managing Oncology Services During a Major Coronavirus Outbreak: Lessons From the Saudi Arabia Experience
. JCO Glob Oncol
. 2020
Mar
;6
(6
):518
–24
.
[PubMed]
2687-8941124.
Medd
P
, Nagra
S
, Hollyman
D
, Craddock
C
, Malladi
R
. Cryopreservation of allogeneic PBSC from related and unrelated donors is associated with delayed platelet engraftment but has no impact on survival
. Bone Marrow Transplant
. 2013
Feb
;48
(2
):243
–8
.
[PubMed]
0268-3369125.
Stockschläder
M
, Hassan
HT
, Krog
C
, Krüger
W
, Löliger
C
, Horstman
M
, et al. Long-term follow-up of leukaemia patients after related cryopreserved allogeneic bone marrow transplantation
. Br J Haematol
. 1997
Feb
;96
(2
):382
–6
.
[PubMed]
0007-1048126.
Koh
M
, Aljurf
M
, Greinix
H
, Weisdord
D
. Coronavirus and Haematopoietic Stem Cell Transplantation. Worldwide Network for Blood & Marrow Transplantation
. WBMT
; 2020
.127.
Coronavirus disease COVID-19: European Society for Blood and Marrow Transplantation (EBMT) Recommendations Update
May
18
, 2020
. Available from: https://www.ebmt.org/sites/default/files/2020-05/EBMT%20COVID-19%20guidelines%20v.8.1.2%20%282020-05-17%29.pdf. Accessed on 6 June 2020.© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
